|
Volumn 21, Issue 12, 2011, Pages 3730-3733
|
Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands
|
Author keywords
Design; Drug resistant; HIV 1 protease inhibitors; Hydroxyprolinamide; P2 ligand; Synthesis
|
Indexed keywords
DARUNAVIR;
HYDROXYPROLINAMIDE DERIVATIVE;
PROTEINASE INHIBITOR;
UNCLASSIFIED DRUG;
ARTICLE;
BINDING SITE;
DRUG DESIGN;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IC 50;
LIGAND BINDING;
MOLECULAR DOCKING;
SUBSTITUTION REACTION;
VIRUS INHIBITION;
AMIDES;
BINDING SITES;
DRUG DESIGN;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
HYDROXYPROLINE;
INHIBITORY CONCENTRATION 50;
LIGANDS;
MOLECULAR STRUCTURE;
SULFONAMIDES;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 79957866241
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.04.070 Document Type: Article |
Times cited : (10)
|
References (20)
|